However, the large size and the lack of mutational hotspots in these genes make traditional Sanger sequencing-based diagnosis, even for the diagnosis of germline BRCA1/2 mutations, laborious and time consuming and, for somatic mutations, unreliable due to tumor heterogeneity. Here, BRCA1 is linked to neoplasm.